Pediatric RSV Vaccine
JBR Clinical Research is conducting a clinical research study of a RSV vaccine for Infants. Space is limited, see if your child qualifies.
No cost pediatric RSV vaccine is available for qualified participants
JBR Clinical Research is conducting a clinical research study of an investigational RSV vaccine.
Why participate in this clinical research study?
– Clinical studies are what allow all medications to come to market, including drugs that treat pain, infections, and various medical conditions. Without clinical studies, no medications would be available for use and they are only possible with the help of participants like you. Compensation varies by study and time involved, and whether you complete all visits and procedures in the study. Every volunteer study at JBR Clinical Research is approved and monitored by an Institutional Review Board (IRB) to make sure the risks are as low as possible and are worth any potential benefits to the volunteer.
What to expect.
Patients that qualify for the study, may receive no cost investigational RSV vaccine and study related care by our board-certified pediatrician. There are up to 6 visits over a 17-months.
Space in the pediatric RSV vaccine study is limited. In order to be considered for the study, please fill out and submit your information on the form.
RSV VACCINE STUDY DETAILS
Who Can Participate?
- Infants ≤ 1 year of age
- Male or Female
- Born ≥ 35 weeks gestation
- Cannot have a history of the RSV infection
Participants May Receive:
- Study related care
- No Cost Pediatric RSV vaccine
- Compensation for time and travel
State of the Art Facilities
JBR Clinical Research is Utah’s premier clinical research organization. For over 30 years, we’ve helped improve the quality of life for everyone by researching new medications and treatments. Our state-of-the-art facilities are held to the highest standards of cleanliness and quality.
Board Certified Physicians
Your safety is our greatest concern. Every procedure at JBR Clinical Research is overseen by and expert medical staff and performed by some of the most well-respected board-certified physicians in the industry, each with many years of experience in their respective specialties.
FDA Approved Procedures
Rest assured; you are not signing up for an “experimental” procedure. JBR Clinical Research only performs FDA approved procedures as if you were at any other hospital or clinic. Our research is focused on the pain medication associated with that procedure.
What is RSV?
Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract. It’s so common that most children have been infected with the virus by age 2. Respiratory syncytial virus can also infect adults.
What are the Symptoms?
Signs and symptoms of respiratory syncytial virus infection most commonly appear about four to six days after exposure to the virus.
Infants are most severely affected by RSV. You may notice your child’s chest muscles and skin pull inward with each breath. This is a sign that he or she is struggling to breathe. Other signs and symptoms of severe RSV infection in infants include:
- Short, shallow and rapid breathing
- Poor feeding
- Unusual tiredness (lethargy)
Most children and adults recover in one to two weeks, although some might have repeated wheezing. Severe or life-threatening infection requiring a hospital stay may occur in premature babies or infants and adults who have chronic heart or lung problems.
Respiratory syncytial virus enters the body through the eyes, nose or mouth. It spreads easily through the air on infected respiratory droplets. You or your child can become infected if someone with RSV coughs or sneezes near you. The virus also passes to others through direct contact, such as shaking hands.
The virus can live for hours on hard objects such as countertops, crib rails and toys. Touch your mouth, nose or eyes after touching a contaminated object and you’re likely to pick up the virus. An infected person is most contagious in the first few days after infection. However, the virus may continue to spread for up to a few weeks.
If you are interested in finding out if your child could be a candidate for the RSV study, please fill out the form on this page. A representative from JBR Clinical Research will be in contact with you to discuss eligibility and next steps.
See if you qualify for this study
A JBR Clinical Research representative will be contacting you shortly via phone to complete the qualification process for our Utah site.
Feel free to call us at 801-261-2000.